Fig. 1From: Post-market safety profile of cefiderocol: a real-world pharmacovigilance exploratory analysis based on U.S. FDA adverse event reporting system (FAERS)The flow diagram of selecting target drug AEs in the overall population from FAERS databaseBack to article page